These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 171434)

  • 1. Inhibition of in vitro growth of lymphoma cells by macrophages from tumor-bearing mice.
    Kirchner H; Holden HT; Herberman RB
    J Natl Cancer Inst; 1975 Oct; 55(4):971-5. PubMed ID: 171434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective cytotoxic T-cell generation in Moloney murine sarcoma virus-infected A/Sn mice.
    Becker S; Klein E
    J Natl Cancer Inst; 1980 Oct; 65(4):811-6. PubMed ID: 6968372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.
    Kirchner H; Muchmore AV; Chused TM; Holden HT; Herberman RB
    J Immunol; 1975 Jan; 114(1 Pt 1):206-10. PubMed ID: 122986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro cytotoxicity of peritoneal macrophages activated with Mycobacterium smegmatis.
    Yamamoto S; Tokunaga T
    Microbiol Immunol; 1978; 22(1):27-40. PubMed ID: 661626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immunity to murine sarcoma virus-induced tumors as measured by macrophage migration inhibition assays.
    Landolfo S; Herberman RB; Holden HT
    J Natl Cancer Inst; 1977 Dec; 59(6):1675-83. PubMed ID: 200758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of tumor growth by peritoneal macrophages of normal and tumor-bearing mice.
    Gabizon A; Trainin N
    Adv Exp Med Biol; 1979; 121B():485-91. PubMed ID: 317562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cell-mediated cytotoxicity against tumor-associated antigens by suppressor cells from tumor-bearing mice.
    Glaser M; Kirchner H; Holden HT; Herberman RB
    J Natl Cancer Inst; 1976 Apr; 56(4):865-7. PubMed ID: 1255803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune reactivity in the Moloney strain of murine sarcoma virus oncogenesis: requirement of thymus-derived lymphocytes for in vivo protection.
    Collavo D; Colombatti A; Biasi G; Chieco-Bianchi L; Davies AJ
    J Natl Cancer Inst; 1976 Mar; 56(3):603-8. PubMed ID: 176399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents.
    Germain RN; Williams RM; Benacerraf B
    J Natl Cancer Inst; 1975 Mar; 54(3):709-20. PubMed ID: 1091741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-T-cell-mediated cytotoxicity in mice with tumors induced by Moloney murine sarcoma virus (M-MuSV). II. Granulocyte-mediatd cytotoxicity against autochthonous target cells isolated from M-MuSV-induced tumors.
    Becker S; Haskill S
    J Natl Cancer Inst; 1980 Aug; 65(2):469-75. PubMed ID: 6249952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-T-cell-mediated cytotoxicity in MSV tumor-bearing mice. III. Macrophage-mediated cytotoxicity against autochthonous MSV tumor-isolated target cells.
    Becker S; Haskill S
    Int J Cancer; 1980 Apr; 25(4):535-41. PubMed ID: 6966262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
    Gabizon A; Leibovich SJ; Goldman R
    J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F; Jongeneel V; Cerottini JC; Brunner KT
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural cell-mediated immunity to lymphoma cells. I. Characteristics of effector cells in a cytostasis assay in vitro.
    Tufveson G; Riesenfeld I; Rönnblom L; Hedman A; Alm GV
    J Natl Cancer Inst; 1977 Nov; 59(5):1491-7. PubMed ID: 302867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed lymphocyte/tumor-cell interaction in a murine sarcoma virus (Moloney)-induced tumor system. Comparison between lymphoproliferation and lymphocyte cytotoxicity.
    Kirchner H; Glaser M; Holden HT; Herberman RB
    Int J Cancer; 1976 Mar; 17(3):362-9. PubMed ID: 1254360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allograft cytotoxicity co-operation between alloimmune T cells and macrophages.
    Jones B; Jones TC
    Immunology; 1978 Feb; 34(2):247-55. PubMed ID: 414994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary cell-mediated cytotoxic response to syngeneic mouse tumor challenge.
    Holden HT; Kirchner H; Herberman RB
    J Immunol; 1975 Aug; 115(2):327-31. PubMed ID: 168259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells.
    Kearney R; Basten A; Nelson DS
    Int J Cancer; 1975 Mar; 15(3):438-50. PubMed ID: 1079792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of the leukocyte adherence inhibition response to murine-sarcoma-virus-induced tumors by tumor-associated suppressor cells.
    Mortensen RF; Elson LM
    Oncology; 1980; 37(6):406-10. PubMed ID: 6253859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.